Nature and the Nature research journals press releaseMarch 22, 2005[1] Predicting stroke risk in sickle cell anemia DOI: 10.1038/ng1533 A new study published in the April issue of Nature Genetics provides a predictive model that can identify sickle cell anemia (SCA) patients at risk of stroke with greater accuracy and faster than current methods allow, which may be useful as a prognostic test. Stroke is a major risk factor for sickle cell anemia patients under 20 years of age.
Paola Sebastiani, Marco Ramoni and colleagues analyzed 235 variations in 80 candidate genes in 1,398 sickle cell anemia patients, in order to develop a model that captured the genetic and clinical factors that influenced the risk of stroke. The authors validated the model in an independent population of 114 subjects, correctly predicting the occurrence of stroke with 98.2% accuracy. The analysis found that 25 variations within 11 genes, combined with 4 clinical variables, interact to significantly influence the risk of stroke. These include some factors previously associated with stroke in the general population, including 3 genes in the TGF-beta pathway as well as hemoglobin levels. This provides evidence that stroke risk is a complex trait with multiple genetic and clinical influences, and suggests candidates that may be important in predicting stroke risk in the general population. Currently, Transcranial Doppler (TCD) flow studies are used to predict the likelihood of stroke in children and young adults with SCA. However, the usefulness of this as a predictive test is limited, as only 10% of cases with abnormal TCD values will have a stroke, while some individuals with normal values will have a stroke. Author Contact: Marco Ramoni (Harvard Medical School, Boston, MA, USA) Tel: +1 617 525 4466, Cell: +1 617 823 7468, Email: marco_ramoni@harvard.edu Paola Sebastiani (Boston University School of Public Health, Boston, MA, USA) Tel: +1 617 638 5877, Email: sebas@bu.edu Other papers from Nature Genetics to be published online at the same time and with the same embargo: [2] Reverse engineering of regulatory networks in human B cells DOI: 10.1038/ng1532 [3] An empirical test of the mutational landscape model of adaptation using a single-stranded DNA virus DOI: 10.1038/ng1535 ***** NATURE CELL BIOLOGY (http://www.nature.com/naturecellbiology) [4] Wnt signals two ways to a healthy gut DOI: 10.1038/ncb1240 The same signal that ensures that there are cells available to keep your intestine replenished also controls a cell type that is required to defend against bacterial infection, according to a study published online this week in Nature Cell Biology. The Wnt signalling system is known to control the turnover of cells in the gut, and over-activation of this system leads to intestinal tumours. The new findings from Dr. Hans Clevers and colleagues bring a note of caution for cancer therapies aimed at blocking Wnt signalling because this could also adversely affect the availability of these bacterial defence cells. Wnt signals are known to be necessary for maintaining a pool of undifferentiated intestinal progenitor cells, which can replenish all the different cell types of the intestine in response to injury among other things. This new study shows that Wnt signals also control both the maturation and the correct positioning of a specific type of intestine cell -- the Paneth cell --which is known to be important for secreting anti-bacterial peptides. This dual role of Wnt -- maintaining a progenitor cell while also inducing a mature cell -- is demonstrated by the observation that intestinal tumour cells, resulting from overproduction of the progenitor cells, also show some molecular characteristics of mature Paneth cells. Author contact: Dr. Hans Clevers (Netherlands Institute for Developmental Biology, Utrecht, The Netherlands) Tel: +31 302121826, Email: clevers@niob.knaw.nl ***** Nature journals to be published online at the same time and with the same embargo: NATURE MATERIALS (http://www.nature.com/naturematerials) [5] Trans-interface diffusion-controlled coarsening DOI: 10.1038/nmat1340 [6] Spin-conserving carrier recombination in conjugated polymers DOI: 10.1354/nmat1354 [7] Duality of fatigue failures of materials caused by Poisson defect statistics of competing failure modes DOI: 10.1051/nmat1351 [8] Quantum criticality and universal scaling of a quantum antiferromagnet DOI: 10.1327/nmat1327 NATURE MEDICINE (http://www.nature.com/naturemedicine) [9] A new transgene reporter for in vivo magnetic resonance imaging DOI: 10.1038/nm1208 [10] Somatostatin regulates brain amyloid beta peptide Abeta 42 through modulation of proteolytic degradation DOI: 10.1038/nm1206 [11] Angiopoietin-related growth factor antagonizes obesity and insulin resistance DOI: 10.1038/nm1214 NATURE NEUROSCIENCE (http://www.nature.com/natureneuroscience) [12] AlphaCaMKII autophosphorylation contributes to rapid learning but is not necessary for memory DOI: 10.1038/nn1431 [13] G protein beta-gamma directly regulates SNARE protein fusion machinery for secretory granule exocytosis DOI: 10.1038/nn1423 [14] Protocadherin Celsr3 is crucial in axonal tract development DOI: 10.1038/nn1428 [15] Virtual lesions of the anterior intraparietal area disrupt goal-dependent on-line adjustments of grasp DOI: 10.1038/nn1430 NATURE STRUCTURAL AND MOLECULAR BIOLOGY (http://www.nature.com/natstructmolbiol) [16] The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core particle DOI: 10.1038/nsmb914 [17] Mechanism of nonhomologous end-joining in mycobacteria: a low-fidelity repair system driven by Ku, ligase D and ligase C DOI: 10.1038/nsmb915 Nature Publishing Group Reference | |||||||||||||||||||||
|
Related Stroke News Articles Antidepressants need new nerve cells to be effective, researchers find Researchers at UT Southwestern Medical Center have discovered in mice that the brain must create new nerve cells for either exercise or antidepressants to reduce depression-like behavior. Tiny 3-D ultrasound probe guides catheter procedures An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance. Not all fat is created equal A Temple University study finds fat in obese patients is "sick" when compared to fat in lean patients. Common treatment to delay labor decreases preterm infants' risk for cerebral palsy Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, M.D., and published in the Aug. 28 issue of The New England Journal of Medicine. Anti-psychotic drug use in the elderly increases despite drug safety warnings Three regulatory warnings of serious adverse events slowed the growth of use of atypical antipsychotic drugs among elderly patients with dementia, but they did not reduce the overall prescription rate of these drugs. Study reveals how blood flow force prevents clogged arteries Machines on cell surfaces, mechanical and lifeless as bed springs, protect blood vessels by responding to blood flow force, according to research published today in the Journal of Cell Biology. New hope for stroke patients If a stroke patient doesn't get treatment within approximately the first three hours of symptoms, there's not much doctors can do to limit damage to the brain. Joslin study identifies protein that produces 'good' fat A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity. Stroke and SIDS in Alaska topics of neuroscience conference University of Alaska Fairbanks neuroscientists studying stroke and Sudden Infant Death Syndrome will present their research findings at the 7th Conference of the Specialized Neuroscience Research Programs in New York Aug. 19-22, 2008. Children's national co-leads nationwide study of landmark sickle cell treatment Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease. More Stroke News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||